key: cord-0882756-iqah5jpp
authors: Gris, Jean‐Christophe; Quéré, Isabelle; Pérez‐Martin, Antonia; Lefrant, Jean‐Yves; Sotto, Albert
title: Uncertainties on the prognostic value of D‐dimers in COVID‐19 patients
date: 2020-05-28
journal: J Thromb Haemost
DOI: 10.1111/jth.14876
sha: 3fc08648d4db36e33570f065891c56e005d64689
doc_id: 882756
cord_uid: iqah5jpp

We read with great interest the paper by Zhang and colleagues [1], describing the predictive value of D-dimers tested on admission on in-hospital mortality in patients with Covid-19. These interesting results may supply an easy-to practice laboratory marker to clinical teams managing the patients. However, a number of uncertainties must be mentioned.

We read with great interest the paper by Zhang and colleagues 1 describing the predictive value of D-dimers tested on admission on in-hospital mortality in patients with Covid-19. These interesting results may supply an easy-to practice laboratory marker to clinical teams managing the patients. However, a number of uncertainties must be mentioned.

First, this is a purely retrospective study, focused on patients who had a D-dimer testing at admission. It was not stated why these peculiar patients had D-dimer testing. The total number of patients from which this studied subgroup was selected is not given. Sixth, as suggested by the authors, this is a purely univariate analysis, a multivariate analysis is strongly lacking, and we do not know the impact of confounders (some laboratory markers being also strongly associated with prognosis in the paper) on the claimed strong predictive value of D-dimers.

The authors have to be congratulated for their very initial data, which now have to be consolidated using strong methodological approaches. This has been difficult in the emergency of such an outbreak situation, but must now be prioritized. The underlying meaning of increased D-dimer levels in Covid-19 patients must be clearly understood, the prevailing interpretation has been coagulation activation finally leading to disseminated intravascular coagulation, which is probably true in the most severe patients and near-fatal outcome but

that have yet to be demonstrated in the initial disease despite striking high D-dimer levels. This has strong clinical consequences, as the observed high D-dimer levels have induced spontaneous therapeutic interventions and experts' recommendations increasing the antithrombotic/anticoagulant dosages, thus increasing the hemorrhagic risk. The mechanisms, determinants, roots, and independent value of increased D-dimers in Covid-19 patients must be fully understood to propose the most pathophysiologically relevant treatments to test.

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

All authors declare having no competing conflicts of interest.

All authors contributed to the writing of this letter and approved its